Skip to main content
. 2021 Oct 1;7:55. doi: 10.1186/s40942-021-00325-5

Table 1.

Currently available anti-VEGF therapies

Generic Brand name, manufacturer Target/mechanism
Pegaptanib sodium Macugen; Bausch and Lomb, Rochester, New York 165 isoform of VEGF-A
Bevacizumab Avastin; Genentech, San Francisco, California All isoforms of VEGF-A
Ranibizumab Lucentis; Genentech, South San Francisco, California All isoforms of VEGF-A
Aflibercept Eylea; Regeneron, Tarrytown, New York VEGF-A and B, placental growth factor (PGF)
Brolucizumab Beovu; Novartis, Logo, Basel VEGF-A